Automating the ""Proteomics Street""

Volume 16 | Issue 13 | 38 | Jun. 24, 2002 Previous | Next Automating the 'Proteomics Street' Tecan aims to streamline the proteomics workflow | By Jeffrey M. Perkel Swiss company Tecan is marketing the first two instruments in its ProTeam™ product line, intended to help automate "the complete proteomics street," from sample fractionation to mass spectrometry (MS) sample preparation, acco

Written byJeffrey Perkel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Swiss company Tecan is marketing the first two instruments in its ProTeam™ product line, intended to help automate "the complete proteomics street," from sample fractionation to mass spectrometry (MS) sample preparation, according to Christoph Eckerskorn, chief scientific officer of Tecan Proteomics.

Traditionally, proteomics researchers prepare crude protein extracts from the cells or tissues under study, separate the proteins on two-dimensional (2D) gels, compare the protein patterns between two gels, and choose proteins whose levels have changed. They then identify and characterize these proteins using MS. Generally, Eckerskorn says, as many as 2,000 individual proteins can be visualized in this manner. The problem, he says, is that a cell contains at least 100,000 proteins; those missing proteins "are below the tip of the iceberg, the low-abundance proteins."

The ProTeam FFE (free-flow electrophoresis) is designed to address this problem. Eckerskorn describes FFE as "gel electrophoresis without the gel." Up to gram-sized quantities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies